Clinical trial
The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression: A Non-inferiority Cluster-randomized Controlled Trial in Dar es Salaam, Tanzania
NCT02711293 is registered in ClinicalTrials.gov with Harvard School of Public Health (HSPH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression: A Non-inferiority Cluster-randomized Controlled Trial in Dar es Salaam, Tanzania
- Lead sponsor
- Harvard School of Public Health (HSPH)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- February 28, 2018
- Enrollment
- 2,172 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antiretroviral therapy, highly active, community health workers, hiv